Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 12/20 | 0.65 |
| ▸ | GIPR | P48546 | 6/20 | 0.65 |
| ▸ | GCGR | P47871 | 3/20 | 0.65 |
| ▸ | NPY1R | P25929 | 1/20 | 0.65 |
| ▸ | NPY2R | P49146 | 1/20 | 0.65 |
| ▸ | NPY4R | P50391 | 1/20 | 0.65 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.65 |
| ▸ | CALCA | P06881 | 2/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30666381 | 0.96 | CALCA (0.65) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30843895 | 0.94 | NPY1R (0.69) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30666385 | 0.91 | NPY1R (0.69) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL31182780 | 0.91 | C5AR1 (0.66) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30843900 | 0.91 | CALCA (0.62) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30843897 | 0.91 | NPY1R (0.64) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30843899 | 0.91 | CXCR4 (0.63) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL31664364 | 0.90 | NPY1R (0.67) | GLP1RGIPRGCGRNPY1RNPY2R | |
| SCHEMBL30658244 | 0.90 | NPY2R (0.76) | GLP1RNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30906444 | 0.89 | CALCA (0.65) | GLP1RGIPRGCGRNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117603309-A | Peptides for the treatment of cancer and uses thereof | 主流源生物科技(上海)有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117603309-A | Peptides for the treatment of cancer and uses thereof | 主流源生物科技(上海)有限公司 | 2024-02-27 | — | — | CN | disclosed |